| Title | Molecular Medicine |
| Abbreviation | Mol. Med. |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Genetics (Q1); Genetics (clinical) (Q1); Molecular Biology (Q1); Molecular Medicine (Q1) |
| h-index | 136 |
| Overall Rank/Ranking | 1815 |
| SCImago Journal Rank (SJR) | 1.752 |
| Impact Score | 6.43 |
| Publisher | BioMed Central Ltd |
| Country | United Kingdom |
| ISSN | 10761551, 15283658 |
| Best Quartile | Q1 |
| Coverage History | 1994-2025 |
Molecular Medicine strives to understand normal body functioning and disease pathogenesis at the molecular level which may allow researchers and physician-scientists to use that knowledge in the design of specific molecular tools for disease diagnosis, treatment, prognosis, and prevention. Manuscripts submitted to the journal should maintain this focus and describe the implications for human disease, at a level approachable by the broad readership of Molecular Medicine. The 2008 Journal Citation Report, showing impact factors calculated from citations of articles published in 2007 and 2006, lists Molecular Medicine with an impact factor of 3.411, putting it in the top 15% of publications.
Molecular Medicine is a journal covering the technologies/fields/categories related to Genetics (Q1); Genetics (clinical) (Q1); Molecular Biology (Q1); Molecular Medicine (Q1). It is published by BioMed Central Ltd. The overall rank of Molecular Medicine is 1815. According to SCImago Journal Rank (SJR), this journal is ranked 1.752. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 136. The best quartile for this journal is Q1.
The ISSN of Molecular Medicine journal is 10761551, 15283658. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Molecular Medicine is cited by a total of 3150 articles during the last 3 years (Preceding 2024).
The Impact IF 2024 of Molecular Medicine is 6.43, which is computed in 2025 as per its definition. Molecular Medicine IF is increased by a factor of 0.93 and approximate percentage change is 16.91% when compared to preceding year 2023, which shows a rising trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2024 of Molecular Medicine is 6.43. If the same upward trend persists, Impact IF may rise in 2025 as well.
| Year | Impact IF |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 6.43 |
| 2023 | 5.50 |
| 2022 | 5.40 |
| 2021 | 5.51 |
| 2020 | 5.69 |
| 2019 | 4.12 |
| 2018 | 2.85 |
| 2017 | 3.29 |
| 2016 | 3.43 |
| 2015 | 3.33 |
| 2014 | 4.54 |
Molecular Medicine has an h-index of 136. It means 136 articles of this journal have more than 136 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Molecular Medicine is 10761551, 15283658. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Molecular Medicine is 1815. According to SCImago Journal Rank (SJR), this journal is ranked 1.752. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 1.752 |
| 2023 | 1.446 |
| 2022 | 1.245 |
| 2021 | 1.346 |
| 2020 | 1.844 |
| 2019 | 1.269 |
| 2018 | 1.403 |
| 2017 | 1.555 |
| 2016 | 1.449 |
| 2015 | 2.222 |
| 2014 | 2.696 |
| Year | Ranking |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 1815 |
| 2023 | 2414 |
| 2022 | 2905 |
| 2021 | 2537 |
| 2020 | 1553 |
| 2019 | 2978 |
| 2018 | 2532 |
| 2017 | 2163 |
| 2016 | 2506 |
| 2015 | 1193 |
| 2014 | 808 |
Molecular Medicine is published by BioMed Central Ltd. It's publishing house is located in United Kingdom. Coverage history of this journal is as following: 1994-2025. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Molecular Medicine is Mol. Med.. This abbreviation ('Mol. Med.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Genetics (Q1); Genetics (clinical) (Q1); Molecular Biology (Q1); Molecular Medicine (Q1), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Molecular Medicine latest impact IF is 6.43. It's evaluated in the year 2024. The highest and the lowest impact IF or impact score of this journal are 6.43 (2024) and 2.85 (2018), respectively, in the last 11 years. Moreover, its average IS is 4.55 in the previous 11 years.
The Molecular Medicine has an SJR (SCImago Journal Rank) of 1.752, according to the latest data. It is computed in the year 2025. In the past 11 years, this journal has recorded a range of SJR, with the highest being 2.696 in 2014 and the lowest being 1.245 in 2022. Furthermore, the average SJR of the Molecular Medicine over the previous 11-year period stands at 4.55.
The latest h-index of the Molecular Medicine is 136.
The Molecular Medicine is published by the BioMed Central Ltd, with its country of publication being the United Kingdom.
The Molecular Medicine is currently ranked 1815 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 11 years, this journal has experienced varying rankings, reaching its highest position of 808 in 2014 and its lowest position of 2978 in 2019.
The standard ISO4 abbreviation for the Molecular Medicine is Mol. Med..
Molecular Medicine is classified as a journal that the BioMed Central Ltd publishes.
The Molecular Medicine encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Molecular Medicine is assigned the following International Standard Serial Numbers (ISSN): 10761551, 15283658.
The best quartile for the Molecular Medicine is Q1 (2024).
The Molecular Medicine coverage history can be summarized as follows: 1994-2025.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Zeitschrift fur Germanistische Linguistik | journal | 27452 | Walter de Gruyter GmbH | 17 | 0.29 |
| Revue Francophone des Laboratoires (discontinued) | journal | 23244 | Elsevier Masson s.r.l. | 8 | 0.00 |
| European Journal of Education | journal | 4974 | Wiley-Blackwell Publishing Ltd | 63 | 5.08 |
| Educational Measurement: Issues and Practice | journal | 6760 | Wiley-Blackwell Publishing Ltd | 68 | 1.54 |
| Libyan Studies | journal | 21508 | Cambridge University Press | 10 | 0.14 |
| Built Environment | journal | 16252 | Alexandrine Press | 51 | 0.95 |
| Epigenetics | journal | 4304 | Taylor and Francis Ltd. | 117 | 3.37 |
| Journal des Professionnels de l'Enfance | journal | 30098 | TPMA | 2 | 0.00 |
| Physics and Chemistry of the Earth | journal | 12927 | Pergamon Press Ltd. | 33 | 0.00 |
| Transboundary and Emerging Diseases | journal | 5531 | John Wiley and Sons Ltd | 92 | 3.26 |
| Year | Impact Score (IS) |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 6.43 |
| 2023 | 5.50 |
| 2022 | 5.40 |
| 2021 | 5.51 |
| 2020 | 5.69 |
| 2019 | 4.12 |
| 2018 | 2.85 |
| 2017 | 3.29 |
| 2016 | 3.43 |
| 2015 | 3.33 |
| 2014 | 4.54 |
